Singular Genomics Systems Inc (OMIC)
21.65
-0.25
(-1.14%)
USD |
NASDAQ |
Nov 22, 16:00
21.65
0.00 (0.00%)
After-Hours: 20:00
Singular Genomics Systems Revenue (TTM): 2.666M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.666M |
| June 30, 2024 | 2.722M |
| March 31, 2024 | 2.49M |
| Date | Value |
|---|---|
| December 31, 2023 | 2.911M |
| September 30, 2023 | 2.595M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.49M
Minimum
Mar 2024
2.911M
Maximum
Dec 2023
2.677M
Average
2.666M
Median
Sep 2024
Revenue (TTM) Benchmarks
| Bruker Corp | 3.241B |
| Azenta Inc | 656.32M |
| Harvard Bioscience Inc | 97.73M |
| Bionano Genomics Inc | 33.33M |
| Akoya Biosciences Inc | 86.82M |